Vancomycin Xellia 250 mg, kapseli, kova, Vancomycin Xellia 125 mg, kapseli, kova clinical trials

The efficacy of oral vancomycin therapy in managing different phenotypes of paediatric inflammatory bowel diseases by correlating treatment response to commensal microbiota composition and function (VERDA)

This study looks at how a medicine called vancomycin helps children with ulcerative colitis. Researchers want to see if it makes children better and how it affects the gut's tiny living things (microbes) to help discover new treatment options for children with this condition.